- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05182411
Validity and Reliability of Turkish Version Leg Activity Measure
Patient-filled scales minimize the burden of data collection for clinicians in a clinical setting.
Therefore, Leg activity measure, a new self-report measure of active and passive function in the leg, has been developed.
Leg activity measure consists of three parts. The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
It is a valid and reliable test in adult neurological patients with lower extremity spasticity. It can be used in the evaluation of the active and passive functions of the results of the clinicians' interventions by making the cultural adaptation of the Turkish language and examining its validity and reliability. We think that it will be important to determine the limitations in activity, participation and daily living activities and to evaluate their reflections.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Spasticity is a common symptom resulting from stroke, brain trauma, and degenerative brain diseases. Spasticity, known as rate-dependent resistance to passive movement, prevents many activities of daily living. Lower extremity spasticity, on the other hand, hinders joint movements and complicates mobility, transfer and passive activities of caregivers.
Goals for the treatment of spasticity often focus on active function improvements in walking, standing, and moving from different sitting positions. However, improvements in passive function tasks and symptom management are often equally important to patients. Active function is the use of the limb to directly perform a task. Passive fonskyion is care of the affected extremity, usually performed by the person himself, but may require assistance from another person.
There is a need for instruments with demonstrable measurement properties that can reflect a clinically significant change in practice. Outcomes developed for treatments such as botulinum toxin and physical interventions for spasticity aimed at improving any aspect of functional performance (active and passive function) should ideally reflect real-life function as opposed to simply observed tasks in the clinical setting.
Leg activity measure filled by the patient consists of three parts. The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
It is a valid and reliable test in adult neurological patients with lower extremity spasticity. It can be used in the evaluation of the active and passive functions of the results of the clinicians' interventions by making the cultural adaptation of the Turkish language and examining its validity and reliability.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Kahramanmaraş, Tyrkia
- Kahramanmaras Sutcu Imam University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- 1 or more spasticity in at least one muscle according to the Modified Ashworth Scale
- Be between the ages of 18-65
- Volunteering to participate in the study
Exclusion Criteria:
- Under 18 years old, over 65 years old
- History of trauma in the last 1 year
- Having alcohol and substance abuse
- Having a pregnancy
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Patients with spasticity
adult neurological patients with spasticities in their lower extremities
|
Turkish version of Leg Activity Measure Rivearmead Mobility Index Nottingham Health Profile Functional Independence Measures
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Turkish version of Leg Activity Measure
Tidsramme: First day
|
Leg activity measure consists of three parts.
The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
The questions in each section are scored between 0-4.
An increase in the score indicates that the activity could not be performed.
|
First day
|
Turkish version of Leg Activity Measure
Tidsramme: 2 weeks later
|
Leg activity measure consists of three parts.
The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
The questions in each section are scored between 0-4.
An increase in the score indicates that the activity could not be performed.
|
2 weeks later
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
The Rivermead Mobility Index
Tidsramme: First day
|
The Rivermead Mobility Index is appropriate for a range of disabilities that include anything from being bedridden to being able to run
|
First day
|
Nottingham Health Profile (NHP)
Tidsramme: First day
|
The NHP is a patient-reported questionnaire. Respondents tick yes or no boxes to answer questions about their health and its effects on their daily life. The questionnaire is divided into two parts. The first parts comprises 38 questions in six categories: sleep, physical mobility, energy, pain, emotional reactions, and social isolation. The second part of the NHP is made up of seven statements about areas of life that are commonly affected by health: paid employment, jobs around the house, social life, personal relationships, sex life, hobbies and interests, and holidays |
First day
|
The Functional Independence Measure (FIM)
Tidsramme: First day
|
The Functional Independence Measure (FIM) is an instrument that was developed as a measure of disability for a variety of populations and is not specific to any diagnosis. The FIM instrument includes measures of independence for self-care, including sphincter control, transfers, locomotion, communication, and social cognition. Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item. |
First day
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Sykdommer i immunsystemet
- Demyeliniserende autoimmune sykdommer, CNS
- Autoimmune sykdommer i nervesystemet
- Demyeliniserende sykdommer
- Autoimmune sykdommer
- Sår og skader
- Traumer, nervesystemet
- Ryggmargssykdommer
- Multippel sklerose
- Ryggmargsskader
Andre studie-ID-numre
- ipekkkirmaci
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på assessment
-
University of WinchesterUniversity College DublinFullførtSlag | Fysisk aktivitet | Gangart, hemiplegiskStorbritannia
-
Thomas Jefferson UniversityFullførtHematopoetisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForente stater
-
University Hospital, LilleFullførtKognitivt symptom | Evalueringer, Diagnostisk selvFrankrike
-
University of WolverhamptonThe Royal Wolverhampton Hospitals NHS TrustRekrutteringAvansert prostatakarsinomStorbritannia
-
Texas Woman's UniversityFullførtAutismespektrumforstyrrelse
-
University of OklahomaRekrutteringHode- og nakkekreftForente stater
-
Alzheimer's Light LLCRekrutteringMultippel sklerose | Parkinsons sykdom | Alzheimers sykdom | Mild kognitiv svikt | Frontotemporal demens | Vaskulær demens | TBIForente stater
-
Izmir Katip Celebi UniversityFullførtHemiplegi, spastiskTyrkia
-
Mansoura University HospitalFullførtIskemisk hjerneslag | Kognitiv svikt | Utfall, fataltEgypt
-
Neurobehavioral Systems, Inc.National Institutes of Health (NIH)RekrutteringAlzheimers sykdom | Aldring | Kognitiv nedgangForente stater